137 related articles for article (PubMed ID: 15845076)
1. Akt is altered in an animal model of Huntington's disease and in patients.
Colin E; Régulier E; Perrin V; Dürr A; Brice A; Aebischer P; Déglon N; Humbert S; Saudou F
Eur J Neurosci; 2005 Mar; 21(6):1478-88. PubMed ID: 15845076
[TBL] [Abstract][Full Text] [Related]
2. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829
[TBL] [Abstract][Full Text] [Related]
3. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.
Humbert S; Bryson EA; Cordelières FP; Connors NC; Datta SR; Finkbeiner S; Greenberg ME; Saudou F
Dev Cell; 2002 Jun; 2(6):831-7. PubMed ID: 12062094
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
Chandrasekher G; Sailaja D
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 In vivo.
Kermer P; Klöcker N; Labes M; Bähr M
J Neurosci; 2000 Jan; 20(2):2-8. PubMed ID: 10632601
[TBL] [Abstract][Full Text] [Related]
6. AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease.
Liévens JC; Iché M; Laval M; Faivre-Sarrailh C; Birman S
Hum Mol Genet; 2008 Mar; 17(6):882-94. PubMed ID: 18065778
[TBL] [Abstract][Full Text] [Related]
7. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
Giampà C; DeMarch Z; D'Angelo V; Morello M; Martorana A; Sancesario G; Bernardi G; Fusco FR
Eur J Neurosci; 2006 Jan; 23(1):11-20. PubMed ID: 16420411
[TBL] [Abstract][Full Text] [Related]
8. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons.
Matsuzaki H; Tamatani M; Mitsuda N; Namikawa K; Kiyama H; Miyake S; Tohyama M
J Neurochem; 1999 Nov; 73(5):2037-46. PubMed ID: 10537063
[TBL] [Abstract][Full Text] [Related]
9. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
Blázquez C; Chiarlone A; Sagredo O; Aguado T; Pazos MR; Resel E; Palazuelos J; Julien B; Salazar M; Börner C; Benito C; Carrasco C; Diez-Zaera M; Paoletti P; Díaz-Hernández M; Ruiz C; Sendtner M; Lucas JJ; de Yébenes JG; Marsicano G; Monory K; Lutz B; Romero J; Alberch J; Ginés S; Kraus J; Fernández-Ruiz J; Galve-Roperh I; Guzmán M
Brain; 2011 Jan; 134(Pt 1):119-36. PubMed ID: 20929960
[TBL] [Abstract][Full Text] [Related]
10. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor prevents changes in Bcl-2 family members and caspase-3 activation induced by excitotoxicity in the striatum.
Pérez-Navarro E; Gavaldà N; Gratacòs E; Alberch J
J Neurochem; 2005 Feb; 92(3):678-91. PubMed ID: 15659237
[TBL] [Abstract][Full Text] [Related]
12. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced toxicity by rescuing proteasome impairment.
Rangone H; Pardo R; Colin E; Girault JA; Saudou F; Humbert S
J Biol Chem; 2005 Jun; 280(23):22021-8. PubMed ID: 15809304
[TBL] [Abstract][Full Text] [Related]
14. The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin.
Rangone H; Poizat G; Troncoso J; Ross CA; MacDonald ME; Saudou F; Humbert S
Eur J Neurosci; 2004 Jan; 19(2):273-9. PubMed ID: 14725621
[TBL] [Abstract][Full Text] [Related]
15. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.
Ebert AD; Barber AE; Heins BM; Svendsen CN
Exp Neurol; 2010 Jul; 224(1):155-62. PubMed ID: 20227407
[TBL] [Abstract][Full Text] [Related]
17. PI3K/Akt-dependent regulation of the transcription factor myocyte enhancer factor-2 in insulin-like growth factor-1- and membrane depolarization-mediated survival of cerebellar granule neurons.
Wiedmann M; Wang X; Tang X; Han M; Li M; Mao Z
J Neurosci Res; 2005 Jul; 81(2):226-34. PubMed ID: 15931671
[TBL] [Abstract][Full Text] [Related]
18. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P
Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Neuronal Survival by Nucleophosmin 1 (NPM1) Is Dependent on Its Expression Level, Subcellular Localization, and Oligomerization Status.
Pfister JA; D'Mello SR
J Biol Chem; 2016 Sep; 291(39):20787-97. PubMed ID: 27510036
[TBL] [Abstract][Full Text] [Related]
20. [Huntington's disease, towards the end of neuronal death?].
Girault V
Presse Med; 2002 Jul; 31(25):1155. PubMed ID: 12192726
[No Abstract] [Full Text] [Related]
[Next] [New Search]
